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Abstract
Objective—The objective of this study was to examine medical illness and anxiety, depressive,
and somatic symptoms in older medical patients with generalized anxiety disorder (GAD).
Method—A case-control study was designed and conducted in the University of California, San
Diego (UCSD) Geriatrics Clinics. A total of fifty-four older medical patients with GAD and 54
matched controls participated.
Measurements—The measurements used for this study include: Brief Symptom Inventory – 18,
Mini International Neuropsychiatric Interview, and the Anxiety Disorders Interview Schedule.
Results—Older medical patients with GAD reported higher levels of somatic symptoms, anxiety,
and depression than other older adults, as well as higher rates of diabetes and gastrointestinal
conditions. In a multivariate model that included somatic symptoms, medical conditions, and
depressive and anxiety symptoms, anxiety symptoms were the only significant predictors of GAD.
Conclusion—These results suggest first, that older medical patients with GAD do not primarily
express distress as somatic symptoms; second, that anxiety symptoms in geriatric patients should
not be discounted as a byproduct of medical illness or depression; and third, that older adults with
diabetes and gastrointestinal conditions may benefit from screening for anxiety.
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Introduction
Generalized anxiety disorder (GAD) is characterized by excessive and hard-to-control
worry, accompanied by symptoms such as restlessness, trouble sleeping or concentrating,
irritability, fatigue, and muscle tension (American Psychiatric Association, 2000). With
prevalence estimates as high as 7.3%, it is one of the most common anxiety disorders among
older adults and may be among the most common psychiatric conditions overall in this age
group (Beekman et al., 1998; Flint, 2005; Gum, King-Kallimanis, & Kohn, 2009; Riedel-
Heller, Busse, & Angermeyer, 2006). GAD is particularly common in older medical patients
and is associated with disability, increased health service use, poorer quality of life, and
possibly mortality (de Beurs et al., 1999; Porensky et al., 2009; Roy-Byrne & Wagner, 2004;
van Hout et al., 2004; Wetherell et al., 2004). Furthermore, although comorbid anxiety
symptoms and medical illnesses negatively affect the quality of life, GAD is frequently
unrecognized and untreated in older adults (Cully et al., 2006; Sihvo, Hamalainen,
Kiviruusu, Pirkolas, & Isometsa, 2006).
Detection of GAD and other anxiety disorders may be particularly difficult in older people
because cardiovascular, endocrine, gastrointestinal, metabolic, neurologic, and pulmonary
disorders can produce symptoms that mimic anxiety (Kim, Braun, & Kunik, 2001). Results
from psychometric evaluations of anxiety instruments that include somatic items suggest
that scores may be inflated among older medical patients (Wetherell & Gatz, 2005).
Approximately half of older GAD patients develop the disorder in the later part of life (Flint,
2005). Risk factors for anxiety in older adults include chronic health conditions, poor self-
rated health, and functional limitations (Vink, Aartsen, & Schoevers, 2008). It is therefore
likely that, just as some individuals may report anxiety-like symptoms caused by a medical
condition, others may have anxiety discounted in the context of physical health problems.
Somatoform disorders and anxiety and depressive disorders commonly co-occur (Lieb,
Meinlschmidt, & Araya, 2007). Hanel et al. (2009) found that primary care patients with
depression, anxiety, and/or somatoform disorders were significantly older than patients
without a mental disorder, which makes accurate diagnoses particularly complicated for
older adults reporting anxiety symptoms in the context of medical illness. Data from
depression studies also suggest that many older adults express psychological distress
through somatic symptoms (Drayer et al., 2005). Older GAD patients are particularly
sensitive to somatic sensations, and these symptoms subside with successful treatment
(Lenze et al., 2005). Moreover, a 40-year follow-up of GAD patients suggests that the
disorder often transforms into somatization disorder with aging (Rubio & Lopez-Ibor, 2007).
Thus, somatic symptoms and medical conditions in late-life GAD merit attention given the
complexity of the correct classification of symptoms, impact on the quality of life, and
healthcare burden.
This study uses a matched case-control design to test the following hypotheses: (1) older
GAD patients will report more medical illnesses than other older adults, and (2) older GAD
patients will report more somatic symptoms, even after controlling for medical illness and
symptoms of anxiety and depression.
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Methods
Participants
Older adults with GAD in this study (n = 54) were a treatment-seeking convenience sample
recruited from 2004 to 2007 for research on psychotherapeutic treatment of late-life GAD.
Most of them were recruited through responses to a mailing describing the study that was
sent to patients in a university-affiliated geriatric medical practice, and some responded to
advertisements and flyers. Participants were diagnosed with GAD according to the
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria (American
Psychiatric Association, 2000) using the Mini International Neuropsychiatric Interview
(MINI; Sheehan et al., 1998) administered over the telephone by a trained research assistant,
followed within approximately two weeks (average 12.8 days) by an in-person interview
using the Anxiety Disorders Interview Schedule-IV (ADIS-IV; Dinardo, Brown, & Barlow,
1994), administered by a postdoctoral fellow in clinical psychology. A licensed clinical
psychologist reviewed videotapes of eight ADIS-IV interviews for those patients whose
MINI and ADIS-IV results did not agree, and the consensus diagnosis was assigned. The
GAD patients completed the questionnaires and provided data as part of their first study
visit, for which they were compensated with $20.
Patients with comorbid psychiatric conditions were included in the study, as long as GAD
was the primary (e.g., most severe) diagnosis. Almost half (43%) of the GAD samples were
diagnosed with at least one additional psychiatric disorder. Most common diagnoses were
major depression (22%) and panic disorder/agoraphobia (13%).
The comparison participants were drawn from a larger study of anxiety, health, and related
psychological constructs in a nontreatment-seeking convenience sample of San Diego
community residents. This sample included 374 individuals recruited from a mailing list
purchased from a private vendor. The mailing list included individuals residing in San Diego
County whose names were drawn primarily from the white pages of the local telephone
book as well as other public sources of data (e.g., Department of Motor Vehicles records and
property deeds). Participants received a 60 min prepaid phone card for their participation
and completed the questionnaire by mail. For this study, 54 individuals from this mailing list
were matched to the GAD patients by gender and age within 1 year by a computer matching
algorithm to form a control group.
This study complied with the ethical rules for human experimentation that are stated in the
Declaration of Helsinki. It was approved by the University of California, San Diego’s
(UCSD) Human Research Protections Program. All participants provided signed informed
consent.
Measures
The Brief Symptom Inventory-18 (BSI-18; Derogatis, 2001) was used as a measure of
anxiety and depressive symptom severity and somatic symptoms over the past week. The
BSI-18 includes anxiety, depression, and somatization subscales, each with six items rated
on a five-point Likert scale from not at all to extremely. The somatization subscale includes
items assessing dizziness, chest pain, nausea, shortness of breath, numbness/tingling, and
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weakness. Internal consistency was high for all subscales (α’s>0.90). Participants reported
their health problems from a checklist.
Statistical analyses
Analyses were performed with Stata release 10.0 (StataCorp, 2007). First, univariate
comparisons of GAD patients and controls were conducted using Student’s t-tests, corrected
where necessary for unequal variance, Fisher’s exact tests, and McNemar’s test for the
medical conditions. In order to control for family-wise type I error in comparisons for
specific health problems, we applied the Holm–Sidàk step-down procedure (Ludbrook,
1998). Odds ratios (ORs) were then calculated for each medical condition separately using
the same procedure reported above to control for type I error. Next, a series of three
conditional logistic regression equations for matched samples (Breslow, 1982) were
calculated using Stata’s clogit command, with the presence or absence of a GAD diagnosis
as the dependent variable. Conditional regression for case-control studies was initially
developed as a remedy for sparse data biases when there are relatively few covariates
(Greenland, Schwartzbaum, & Finkle, 2000; Hoshmer & Lemeshow, 1989). The first model
included somatic symptoms alone; the second included medical conditions as well as
somatic symptoms, controlling for the overall number of medical conditions other than the
specific conditions included in the model; and the third included somatic symptoms, medical
conditions, and depressive and anxiety symptoms.
Results
Table 1 displays demographic information about the samples. As a group, the GAD patients
were more highly educated and were less likely to be widowed than the community controls.
They also reported higher levels of anxiety and depressive symptoms, and somatic
symptoms. Specific somatic symptoms associated with GAD were numbness or tingling,
t(89.2) = −2.37, p = 0.02, and weakness, t(98.0) = −2.48, p = 0.015. Although education and
marital status differed between the groups, these variables were not related to somatic
symptoms, anxiety, depression, overall number of medical conditions, or any of the specific
medical conditions except one: higher levels of education were associated with a reduced
prevalence of heart disease (r = −0.20, p = 0.04).
According to the unconditional tests, GAD patients were also more likely ( p<0.001) to
report chronic pain, heart disease, diabetes, and respiratory, gastrointestinal, and
neurological conditions as well as cancer. However, as shown in Table 2, when matched
case-control analyses were used, only diabetes remained significantly different between
GAD patients and community controls: McNemar’s χ2(1) = 7.14; p = 0.0075; OR = 6.0
(95% CI: 1.34, 55.20). Likewise, there was a trend for gastrointestinal conditions to be more
prevalent among GAD patients: McNemar’s χ2(1) = 3.56; p = 0.059; OR = 2.6 (95% CI:
0.87, 9.30). None of the other medical conditions differed between the groups.
Table 3 displays results from three logistic regression models. In the first model, somatic
symptoms were associated with the presence of GAD (OR = 1.12, SE = 0.06; z = 2.15, p =
0.031). The pseudo-R2 for this model was 0.08 ( p = 0.019). In the second model, containing
diabetes and gastrointestinal conditions in addition to somatic symptoms, only diabetes was
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a statistically significant predictor of GAD (OR = 7.92, SE = 6.9; z = 2.39, p = 0.017). The
pseudo-R2 for this second model was 0.205 ( p = 0.002). The effect of diabetes remained
significant after controlling for the total number of medical conditions other than diabetes
and gastrointestinal problems (OR = 7.4, SE = 6.2; z = 2.38, p = 0.017). In the third model,
which included diabetes, depressive and anxiety symptoms, and somatic symptoms, only
anxiety symptoms (OR = 3.06, SE = 1.46; z = 2.34, p = 0.019) were significantly associated
with GAD. The pseudo-R2 for this final model was 0.876 ( p<0.001). When anxiety
symptoms were removed from this final model, only depressive symptoms remained
significant (OR = 1.75, SE = 0.3; z = 3.10, p = 0.002).
Discussion
In this sample of older medical patients with GAD and matched community controls, those
with GAD were more likely to report diabetes and gastrointestinal conditions. They also
endorsed higher levels of somatic, anxiety, and depressive symptoms. In models including
medical conditions, depressive, anxiety, and somatic symptoms, only elevated anxiety
symptoms were associated with the presence of GAD. Moreover, the specific somatic
symptoms reported by older GAD patients did not include dizziness or nausea, symptoms
that might be expected to accompany diabetes or gastrointestinal conditions. Rather, the
symptoms more frequently endorsed were relatively nonspecific complaints of numbness
and general weakness.
Other research has documented elevated rates of GAD in patients with gastrointestinal
conditions and diabetes (Grigsby, Anderson, Freedland, Clouse, & Lustman, 2002; Härter,
Conway, & Merikangas, 2003). Even more evidence links GAD and other anxiety disorders
to cardiovascular conditions (Barger & Sydeman, 2005). The fact that we did not find such
an association in this study may be due to the high levels of education among the GAD
patients in our sample, in conjunction with the inverse relationship between education and
heart disease.
Limitations of the study include the fact that control participants were not evaluated for
mood or anxiety disorders and therefore may have included individuals with GAD or other
psychiatric conditions. However, the inclusion of such individuals in the comparison group
would, if anything, lead to more conservative estimates of the associations among medical
conditions, somatic complaints, and anxiety and depressive symptoms in late-life GAD.
Investigation in a larger sample with diagnostic data from the control group is needed to
confirm these preliminary results. A second limitation is the fact that medical conditions
were self-reported and may therefore not be entirely accurate. For example, if the control
group underreported medical conditions relative to the GAD patients, medical illness may
play a smaller role in late-life GAD than our results suggest. Finally, 43% of the GAD
patients had at least one co-existing psychiatric disorder; so, it is possible that the results
could be partially explained by comorbid conditions. We chose to include patients with as
well as without psychiatric comorbidity in this investigation because GAD is frequently
accompanied by other anxiety and mood disorders; thus, to exclude individuals without co-
occurring disorders would result in an unrepresentative sample. We did include a measure of
depression, the most common co-existing diagnosis, in our model.
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In contrast to other studies that found it difficult to differentiate among anxiety,
somatization, and medical illness, older medical patients with GAD in this study did not
express their emotional distress primarily through physical concerns or complaints (Hanel et
al., 2009; Lieb et al., 2007). This is likely because the GAD patients in this sample were
seeking treatment for anxiety. These data do suggest that elevated levels of anxiety in late-
life GAD cannot be explained by medical conditions or depression. Furthermore, although
older GAD patients frequently report somatic symptoms (Lenze et al., 2005), these may not
be as important as other anxiety symptoms when assessing GAD in older adults. Therefore,
the primary screening mechanism should be anxiety focused and may be particularly
warranted for older individuals with diabetes and gastrointestinal conditions. Finally, older
adults may be accurately representing their anxiety symptoms in medical settings and should
be referred to appropriate psychiatric care if anxiety symptoms are reported.
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Table 1
Sample demographics and clinical data.
Variable GAD patients (n = 54) Community controls (n = 54) χ2 or t p
Women 70.4% 70.4% 0.00 1.00
Age (years) 71.7 (6.5) 71.8 (6.5) 0.00 0.95
Caucasian 81.5% 87.0% 0.63 0.43
Education (years) 15.6 (2.9) 13.9 (3.2) −2.88 0.005
Marital status 11.97 0.007
 Never married (%) 7.4 1.9
 Married (%) 53.7 44.4
 Divorced (%) 22.2 9.3
 Widowed (%) 16.7 44.4
Anxiety 6.3 (4.5) 1.2 (1.8) −7.66 <0.001
Depression 6.9 (5.2) 1.4 (3.0) −6.68 <0.001
Somatization 4.0 (4.2) 2.1 (3.4) −2.53 0.01
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Table 2
Distribution of medical conditions and conditional McNemar’s χ2 test results.
Variable GAD (%) Controls (%) p OR (95% CI)a
Osteoarthritis 50.0 55.6 0.590 0.8 (0.4, 1.8)
Other chronic pain conditions 38.9 27.8 0.180 1.9 (0.7, 5.5)
Hypertension 48.1 46.3 0.835 1.1 (0.4, 2.7)
Heart disease 16.7 20.4 0.617 0.8 (0.2, 2.3)
Diabetes 24.1 5.6 0.008 6.0 (1.3, 55.2)
Respiratory conditions 7.4 5.6 0.706 1.33 (0.2, 9.1)
Gastrointestinal conditions 25.9 11.1 0.059 2.6 (0.9, 9.3)
Neurological conditions 7.4 1.9 0.180 4.0 (0.4, 197.0)
Cancer 13.0 7.4 0.317 2.0 (0.4, 12.4)
Total number of medical conditions, Mean (SD) 2.3 (1.4) 1.8 (1.4) 0.050 3.0 (0.9, 12.8)
Note:
aConditional ORs and CIs.
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